Status:
COMPLETED
Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery
Lead Sponsor:
Grupo Español de Rehabilitación Multimodal
Collaborating Sponsors:
Universidad de Zaragoza
Aragon Health Science Institute
Conditions:
Postoperative Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
Multi-center, prospective, cohort study, of patients scheduled for elective rectal surgery who received absorbable hemostatic powder to assess whether it can improve patient postoperative outcomes, re...
Detailed Description
Multimodal surgical rehabilitation, also known as Enhanced Recovery After Surgery, entails the application of a series of perioperative procedure measures and strategies aimed at patients who are goin...
Eligibility Criteria
Inclusion
- All adult patients (aged \>18 years) with a diagnosis of malignant rectal cancer who are scheduled for radical surgery (anterior resection). Informed consent will be obtained from all subjects, who will participate in the study voluntarily.
Exclusion
- Patient refusal, patients undergoing emergency surgery, patients under 18 years of age, existence of other concomitant surgical processes. Previous chemo-radiotherapy. Ileostomy or colostomy. Patients that have receive a drain.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04799379
Start Date
April 1 2021
End Date
June 30 2024
Last Update
July 16 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario de Elche
Elche, Alicante, Spain
2
Hospital de la RIBERA
Alzira, Valencia, Spain
3
Hospital Jimenz diaz
Madrid, Spain
4
Hospital Universitario Infanta Leonor
Madrid, Spain